Business Description
Shu Yu Civilian Pharmacy Corp Ltd
ISIN : CNE100004LT4
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.4 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 1.75 | |||||
Debt-to-EBITDA | 17.6 | |||||
Interest Coverage | 2.37 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.69 | |||||
Beneish M-Score | -2.02 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.7 | |||||
3-Year EBITDA Growth Rate | 29.5 | |||||
3-Year EPS without NRI Growth Rate | -22.8 | |||||
3-Year Book Growth Rate | 10.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.75 | |||||
9-Day RSI | 62.51 | |||||
14-Day RSI | 54.16 | |||||
6-1 Month Momentum % | -31.24 | |||||
12-1 Month Momentum % | -25.49 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 0.66 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 110.77 | |||||
Days Sales Outstanding | 40.22 | |||||
Days Payable | 102.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.87 | |||||
Dividend Payout Ratio | 0.43 | |||||
Forward Dividend Yield % | 0.87 | |||||
5-Year Yield-on-Cost % | 0.92 | |||||
3-Year Average Share Buyback Ratio | -3.6 | |||||
Shareholder Yield % | -22.03 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 27.9 | |||||
Operating Margin % | 2.99 | |||||
Net Margin % | 0.83 | |||||
FCF Margin % | -0.62 | |||||
ROE % | 3.43 | |||||
ROA % | 0.89 | |||||
ROIC % | 3.8 | |||||
ROC (Joel Greenblatt) % | 10.82 | |||||
ROCE % | 5.46 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 64.55 | |||||
PE Ratio without NRI | 48.72 | |||||
Shiller PE Ratio | 28.69 | |||||
PEG Ratio | 1.36 | |||||
PS Ratio | 0.54 | |||||
PB Ratio | 2.31 | |||||
Price-to-Tangible-Book | 11.13 | |||||
Price-to-Operating-Cash-Flow | 29.53 | |||||
EV-to-EBIT | 34.36 | |||||
EV-to-EBITDA | 34.36 | |||||
EV-to-Revenue | 0.81 | |||||
EV-to-FCF | -129.34 | |||||
Price-to-Projected-FCF | 2.19 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.67 | |||||
Price-to-Graham-Number | 4.91 | |||||
Earnings Yield (Greenblatt) % | 2.91 | |||||
FCF Yield % | -1.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shu Yu Civilian Pharmacy Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 9,557.616 | ||
EPS (TTM) (Â¥) | 0.2 | ||
Beta | 0 | ||
Volatility % | 31.15 | ||
14-Day RSI | 54.16 | ||
14-Day ATR (Â¥) | 0.478191 | ||
20-Day SMA (Â¥) | 12.5155 | ||
12-1 Month Momentum % | -25.49 | ||
52-Week Range (Â¥) | 10.01 - 23.9 | ||
Shares Outstanding (Mil) | 405.34 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shu Yu Civilian Pharmacy Corp Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shu Yu Civilian Pharmacy Corp Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shu Yu Civilian Pharmacy Corp Ltd Frequently Asked Questions
What is Shu Yu Civilian Pharmacy Corp Ltd(SZSE:301017)'s stock price today?
When is next earnings date of Shu Yu Civilian Pharmacy Corp Ltd(SZSE:301017)?
Does Shu Yu Civilian Pharmacy Corp Ltd(SZSE:301017) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |